Alexander J Denner Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander J Denner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander J Denner. Alexander J Denner is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in BIOGEN INC. ($IDPH) and Director in VIVUS INC ($VVUS) and 10% Owner in APRICUS BIOSCIENCES, INC. ($APRI) and Director in MEDICINES CO /DE ($MDCO) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Iterum Therapeutics plc ($ITRM) and Director in Bioverativ Inc. ($BIVV).
Latest Insider Trading Transactions of Alexander J Denner
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, IDPH, BIVV, IRWD, ITRM, MDCO, RGLS, SEEL, VVUS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,229 | 0 | 63,074 | 61.8 K to 63.1 K (+1.99 %) |
| Mar 17 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,235 | 0 | 39,079 | 37.8 K to 39.1 K (+3.26 %) |
| Mar 10 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 10.54 | 75,000 | 790,500 | 16,390,000 | 16.3 M to 16.4 M (+0.46 %) |
| Mar 10 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 10.30 | 150,000 | 1,545,000 | 16,315,000 | 16.2 M to 16.3 M (+0.93 %) |
| Mar 05 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 10.01 | 175,000 | 1,751,750 | 16,165,000 | 16 M to 16.2 M (+1.09 %) |
| Mar 05 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 10.00 | 250,000 | 2,500,000 | 15,990,000 | 15.7 M to 16 M (+1.59 %) |
| Mar 05 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 10.02 | 350,000 | 3,507,000 | 15,740,000 | 15.4 M to 15.7 M (+2.27 %) |
| Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 9.56 | 500,000 | 4,780,000 | 15,390,000 | 14.9 M to 15.4 M (+3.36 %) |
| Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 9.60 | 344,900 | 3,311,040 | 14,890,000 | 14.5 M to 14.9 M (+2.37 %) |
| Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Buy | P | 9.20 | 505,100 | 4,646,920 | 14,545,100 | 14 M to 14.5 M (+3.60 %) |
| Feb 12 2021 | ITRM | Iterum Therapeutic ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
| Feb 12 2021 | ITRM | Iterum Therapeutic ... | DENNER ALEXANDER J | 10% Owner | Sell | S | 2.27 | 10,619,949 | 24,107,284 | 0 | 10.6 M to 0 (-100.00 %) |
| Feb 12 2021 | ITRM | Iterum Therapeutic ... | DENNER ALEXANDER J | 10% Owner | Sell | S | 2.59 | 10,000,000 | 25,900,000 | 10,619,949 | 20.6 M to 10.6 M (-48.50 %) |
| Feb 12 2021 | ITRM | Iterum Therapeutic ... | DENNER ALEXANDER J | 10% Owner | Buy | C | 0.00 | 20,619,949 | 0 | 20,616,949 | -3,000 to 20.6 M (-687,331.63 %) |
| Dec 17 2020 | IRWD | IRONWOOD PHARMACEU ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 661 | 0 | 37,844 | 37.2 K to 37.8 K (+1.78 %) |
| Jun 05 2020 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 890 | 0 | 12,954 | 12.1 K to 13 K (+7.38 %) |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | D | 34.81 | 13,410 | 466,802 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | D | 33.86 | 9,141 | 309,514 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | D | 39.39 | 8,577 | 337,848 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | D | 37.22 | 9,700 | 361,034 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | D | 32.86 | 27,230 | 894,778 | 0 | |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 4,202,000 | 0 | 0 | 4.2 M to 0 (-100.00 %) |
| Jan 06 2020 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 85,813 | 0 | 0 | 85.8 K to 0 (-100.00 %) |
| Jan 03 2020 | RGLS | Regulus Therapeuti ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 6.66 | 4,231,620 | 28,182,589 | 6,083,471 | |
| Jan 03 2020 | RGLS | Regulus Therapeuti ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.67 | 423,162 | 281,826 | 423,162 | |
| Jan 03 2020 | RGLS | Regulus Therapeuti ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 6.66 | 4,231,620 | 28,182,589 | 6,083,471 | |
| Jan 03 2020 | RGLS | Regulus Therapeuti ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.67 | 423,162 | 281,826 | 423,162 | |
| Jun 28 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 33.00 | 50,000 | 1,650,000 | 4,202,000 | 4.2 M to 4.2 M (+1.20 %) |
| Jun 28 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 33.00 | 50,000 | 1,650,000 | 4,202,000 | 4.2 M to 4.2 M (+1.20 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,155 | 0 | 12,064 | 10.9 K to 12.1 K (+10.59 %) |
| Jun 03 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | A | 34.81 | 13,410 | 466,802 | 13,410 | |
| Jun 03 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 3,663 | 0 | 14,092 | 10.4 K to 14.1 K (+35.12 %) |
| May 31 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 34.81 | 50,000 | 1,740,500 | 4,152,000 | 4.1 M to 4.2 M (+1.22 %) |
| May 31 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 34.85 | 35,000 | 1,219,750 | 4,102,000 | 4.1 M to 4.1 M (+0.86 %) |
| May 22 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 33.13 | 139,000 | 4,605,070 | 4,067,000 | 3.9 M to 4.1 M (+3.54 %) |
| May 22 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 33.95 | 132,000 | 4,481,400 | 3,928,000 | 3.8 M to 3.9 M (+3.48 %) |
| May 22 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 34.50 | 160,000 | 5,520,000 | 3,796,000 | 3.6 M to 3.8 M (+4.40 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 231.24 | 38,000 | 8,787,120 | 643,000 | 605 K to 643 K (+6.28 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 229.46 | 30,000 | 6,883,800 | 605,000 | 575 K to 605 K (+5.22 %) |
| May 02 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 229.25 | 50,342 | 11,540,904 | 575,000 | 524.7 K to 575 K (+9.60 %) |
| Mar 08 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 24.91 | 248,100 | 6,180,171 | 3,636,000 | 3.4 M to 3.6 M (+7.32 %) |
| Mar 05 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 26.07 | 181,900 | 4,742,133 | 3,387,900 | 3.2 M to 3.4 M (+5.67 %) |
| Mar 05 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 25.45 | 325,000 | 8,271,250 | 3,206,000 | 2.9 M to 3.2 M (+11.28 %) |
| Mar 05 2019 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 25.15 | 100,000 | 2,515,000 | 2,881,000 | 2.8 M to 2.9 M (+3.60 %) |
| Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 328.45 | 7,000 | 2,299,163 | 524,658 | 517.7 K to 524.7 K (+1.35 %) |
| Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 330.52 | 25,800 | 8,527,393 | 517,658 | 491.9 K to 517.7 K (+5.25 %) |
| Feb 01 2019 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 324.86 | 30,000 | 9,745,851 | 491,858 | 461.9 K to 491.9 K (+6.50 %) |
| Dec 21 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 17.89 | 10,000 | 178,900 | 2,781,000 | 2.8 M to 2.8 M (+0.36 %) |
| Dec 18 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 18.18 | 10,000 | 181,800 | 2,771,000 | 2.8 M to 2.8 M (+0.36 %) |
| Dec 18 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 17.91 | 20,000 | 358,200 | 2,761,000 | 2.7 M to 2.8 M (+0.73 %) |
| Dec 17 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 18.97 | 219,000 | 4,154,430 | 2,741,000 | 2.5 M to 2.7 M (+8.68 %) |
| Dec 17 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 20.73 | 600,000 | 12,438,000 | 2,522,000 | 1.9 M to 2.5 M (+31.22 %) |
| Jun 14 2018 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 880 | 0 | 10,909 | 10 K to 10.9 K (+8.77 %) |
| Jun 04 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | A | 33.86 | 9,141 | 309,514 | 9,141 | |
| Jun 04 2018 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 3,766 | 0 | 10,429 | 6.7 K to 10.4 K (+56.52 %) |
| Apr 27 2018 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 269.91 | 48,000 | 12,955,680 | 461,858 | 413.9 K to 461.9 K (+11.60 %) |
| Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 653,409 | |
| Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 653,409 | |
| Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 0 | |
| Mar 23 2018 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | J | 0.71 | 653,409 | 463,920 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 1,165,000 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 5,001 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Feb 02 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
| Nov 30 2017 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Buy | P | 30.03 | 170,000 | 5,105,100 | 1,922,000 | 1.8 M to 1.9 M (+9.70 %) |
| Nov 30 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 319.84 | 10,000 | 3,198,400 | 413,858 | 403.9 K to 413.9 K (+2.48 %) |
| Nov 30 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 316.12 | 20,000 | 6,322,400 | 403,858 | 383.9 K to 403.9 K (+5.21 %) |
| Sep 01 2017 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 8.80 | 2,835 | 24,948 | 672,453 | |
| Sep 01 2017 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 1.63 | 6,104 | 9,950 | 1,447,906 | 1.4 M to 1.4 M (+0.42 %) |
| Aug 31 2017 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Grant | A | 36.69 | 7,146 | 262,187 | 1,752,000 | 1.7 M to 1.8 M (+0.41 %) |
| Aug 31 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.69 | 932 | 52,835 | 1,165,000 | 1.2 M to 1.2 M (+0.08 %) |
| Aug 31 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 316.56 | 933 | 295,350 | 383,858 | 382.9 K to 383.9 K (+0.24 %) |
| Jun 09 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,055 | 0 | 10,029 | 9 K to 10 K (+11.76 %) |
| Jun 01 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 55.93 | 90,000 | 5,033,475 | 1,165,000 | 1.1 M to 1.2 M (+8.37 %) |
| May 30 2017 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | A | 39.39 | 8,577 | 337,848 | 8,577 | |
| May 30 2017 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 3,237 | 0 | 6,663 | 3.4 K to 6.7 K (+94.48 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 57.21 | 450,000 | 25,745,130 | 1,075,000 | 625 K to 1.1 M (+72.00 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.98 | 130,000 | 7,147,907 | 625,000 | 495 K to 625 K (+26.26 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.16 | 340,000 | 18,414,400 | 495,000 | 155 K to 495 K (+219.35 %) |
| May 01 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 278.48 | 58,858 | 16,390,776 | 383,858 | 325 K to 383.9 K (+18.11 %) |
| May 01 2017 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 278.58 | 15,000 | 4,178,700 | 325,000 | 310 K to 325 K (+4.84 %) |
| Apr 17 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.83 | 1,056 | 60,012 | 5,001 | 3.9 K to 5 K (+26.77 %) |
| Feb 16 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 9.30 | 3,459,280 | 32,176,493 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 9.30 | 5,340,720 | 49,676,707 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 4.91 | 25,000 | 122,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 6.45 | 25,000 | 161,250 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | D | 8.73 | 75,000 | 654,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 5,051,335 | 0 | 0 | 5.1 M to 0 (-100.00 %) |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 7,798,665 | 0 | 0 | 7.8 M to 0 (-100.00 %) |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 53,173 | 0 | 0 | 53.2 K to 0 (-100.00 %) |
| Feb 02 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
| Feb 02 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 12,500 | 0 | 53,173 | 40.7 K to 53.2 K (+30.73 %) |
| Feb 02 2017 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 5,508 | 0 | 40,673 | 35.2 K to 40.7 K (+15.66 %) |
| Jun 09 2016 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 1,060 | 0 | 8,950 | 7.9 K to 9 K (+13.43 %) |
| May 31 2016 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | A | 37.22 | 9,700 | 361,034 | 9,700 | |
| May 31 2016 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 3,426 | 0 | 3,426 | 0 to 3.4 K |
| Feb 04 2016 | MDCO | MEDICINES CO /DE | DENNER ALEXANDER J | Director | Option Exercise | A | 32.86 | 27,230 | 894,778 | 27,230 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 12,500 | 0 | 35,165 | 22.7 K to 35.2 K (+55.15 %) |
| Mar 07 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.88 | 3,323,864 | 2,925,000 | 6,724,525 | |
| Mar 07 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 0.88 | 6,647,728 | 5,850,001 | 14,479,053 | 7.8 M to 14.5 M (+84.89 %) |
| Jan 14 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Option Exercise | P | 0.88 | 653,409 | 575,000 | 3,400,661 | |
| Jan 14 2016 | APRI | APRICUS BIOSCIENCE ... | DENNER ALEXANDER J | 10% Owner | Buy | P | 0.88 | 1,306,819 | 1,150,001 | 7,831,324 | 6.5 M to 7.8 M (+20.03 %) |
| Nov 03 2015 | VVUS | VIVUS INC | DENNER ALEXANDER J | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
| Oct 26 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 276.77 | 100,000 | 27,677,000 | 310,000 | 210 K to 310 K (+47.62 %) |
| Oct 26 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Buy | P | 277.80 | 210,000 | 58,338,000 | 210,000 | 0 to 210 K |
| Jun 11 2015 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 695 | 0 | 7,890 | 7.2 K to 7.9 K (+9.66 %) |
| May 29 2015 | VVUS | VIVUS INC | DENNER ALEXANDER J | Director | Option Exercise | A | 2.53 | 25,000 | 63,250 | 25,000 |
Page: 1